Why the study?
Does statin therapy reduce major adverse cardiac events in acute myocardial infarction patients with elevated CRP undergoing percutaneous coronary intervention?
Population
340 patients with acute myocardial infarction who underwent percutaneous coronary intervention, divided into…
Comparison
Simvastatin 20-40 mg vs No statin therapy
Design
Cohort
Follow-up
1 year
Authors
Loading...
May support statin use in elevated-CRP AMI post-PCI; hypothesis-generating and requires RCT confirmation.
Does statin therapy reduce major adverse cardiac events in acute myocardial infarction patients with elevated CRP undergoing percutaneous coronary intervention?
Statin therapy significantly attenuates the increased risk for MACE in AMI patients with elevated CRP levels undergoing PCI.
Hong et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: